Kivu Biosciences (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 29, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $92,000,000
Company Info
- Traction
- Kivu plans to start its first clinical trial in solid tumors next year.
- Founders
- Mohit Trikha
- Company Description
- Kivu Biosciences is a biotechnology startup developing targeted drugs for cancer, focusing on antibody-drug conjugates (ADCs) that are more precise and stable, aiming to reduce side effects.
- Market
- Cancer treatment
- Location
- San Francisco, California, USA
- Coinvestors
- Novo Holdings, Gimv, Red Tree Venture Capital, BioGeneration Ventures